[1] |
Macdonald AG, Lynch D, Garbett I, et al. Malignant spinal cord compression[J]. J R Coll Physicians Edinb, 2019, 49(2): 151-156.
|
[2] |
Silva GT, Bergmann A, Thuler LC. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer[J]. Spine J, 2015, 15(6): 1263-1269.
|
[3] |
Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial[J]. Lancet, 2005, 366(9486): 643-648.
|
[4] |
Lei M, Li J, Liu Y, et al. Who are the Best Candidates for Decompressive Surgery and Spine Stabilization in Patients With Metastatic Spinal Cord Compression : A New Scoring System[J]. Spine (Phila Pa 1976), 2016, 41(18): 1469-1476.
|
[5] |
雷明星,刘耀升,周诗国,等. 肺癌脊柱转移瘤脊髓压迫后路减压内固定术生存期预测模型的建立[J]. 中华骨与关节外科杂志,2015, 8(6): 495-501.
|
[6] |
Paulino Pereira NR, Ogink PT, Groot OQ, et al. Complications and reoperations after surgery for 647 patients with spine metastatic disease[J]. Spine J, 2019, 19(1): 144-156.
|
[7] |
Schuss P, Guresir A, Schneider M, et al. Factors influencing early postoperative complications following surgery for symptomatic spinal metastasis: a single-center series and multivariate analysis[J]. Neurosurg Rev, 2020, 43(1): 211-216.
|
[8] |
Tateiwa D, Oshima K, Nakai T, et al. Clinical outcomes and significant factors in the survival rate after decompression surgery for patients who were non-ambulatory due to spinal metastases[J]. J Orthop Sci, 2019, 24(2): 347-352.
|
[9] |
Bouthors C, Prost S, Court C, et al. Outcomes of surgical treatments of spinal metastases: a prospective study[J]. Support Care Cancer, 2020, 28(5): 2127-2135.
|
[10] |
Krisht KM, Mumert ML, Schmidt MH. Management considerations and strategies to avoid complications associated with the thoracoscopic approach for corpectomy[J]. Neurosurg Focus, 2011, 31(4): E14-E21.
|
[11] |
Pascal-Moussellard H, Broc G, Pointillart V, et al. Complications of vertebral metastasis surgery[J]. Eur Spine J, 1998, 7(6): 438-444.
|
[12] |
Ikard RW. Methods and complications of anterior exposure of the thoracic and lumbar spine[J]. Arch Surg, 2006, 141(10): 1025-1034.
|
[13] |
Kumar N, Tan B, Zaw AS, et al. The role of preoperative vascular embolization in surgery for metastatic spinal tumours[J]. Eur Spine J, 2016, 25(12): 3962-3970.
|
[14] |
Ragel BT, Kan P, Schmidt MH. Blood transfusions after thoracoscopic anterior thoracolumbar vertebrectomy[J]. Acta Neurochir (Wien), 2010, 152(4): 597-603.
|
[15] |
Pedreira R, Abu-Bonsrah N, Karim Ahmed A, et al. Hardware failure in patients with metastatic cancer to the spine[J]. J Clin Neurosci, 2017, 45: 166-171.
|
[16] |
Quraishi NA, Rajabian A, Spencer A, et al. Reoperation rates in the surgical treatment of spinal metastases[J]. Spine J, 2015, 15(3 Suppl): S37-S43.
|
[17] |
Amankulor NM, Xu R, Iorgulescu JB, et al. The incidence and patterns of hardware failure after separation surgery in patients with spinal metastatic tumors[J]. Spine J, 2014, 14(9): 1850-1859.
|
[18] |
Kumar N, Patel R, Wadhwa AC, et al. Basic concepts in metal work failure after metastatic spine tumour surgery[J]. Eur Spine J, 2018, 27(4): 806-814.
|
[19] |
Omeis IA, Dhir M, Sciubba DM, et al. Postoperative Surgical Site Infections in Patients Undergoing Spinal Tumor Surgery[J]. Spine, 2011, 36(17): 1410-1419.
|
[20] |
Carl HM, Ahmed AK, Abu-Bonsrah N, et al. Risk factors for wound-related reoperations in patients with metastatic spine tumor[J]. J Neurosurg Spine, 2018, 28(6): 663-668.
|
[21] |
Mesfin A, Sciubba DM, Dea N, et al. Changing the Adverse Event Profile in Metastatic Spine Surgery: An Evidence-Based Approach to Target Wound Complications and Instrumentation Failure[J]. Spine(Phila Pa 1976), 2016, 41(20): S262-S270.
|
[22] |
Igarashi T, Murakami H, Demura S, et al. Risk factors for local recurrence after total en bloc spondylectomy for metastatic spinal tumors: A retrospective study[J]. J Orthop Sci, 2018, 23(3): 459-463.
|
[23] |
Amelot A, Balabaud L, Choi D, et al. Surgery for metastatic spine tumors in the elderly. Advanced age is not a contraindication to surgery![J]. Spine J, 2017, 17(6): 759-767
|
[24] |
Zaw AS, Sonawane D, Maharanjan K, et al. Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery [J]. Spine J, 2017, 17(3): S18-S19.
|
[25] |
Clausen C, Lönn L, Morgen SS, et al. Perioperative blood transfusion does not decrease survival after surgical treatment of spinal metastases[J]. Eur Spine J, 2014, 23(8): 1791-1796.
|
[26] |
Paulino Pereira NR, Langerhuizen DW, Janssen SJ, et al. Are perioperative allogeneic blood transfusions associated with 90-days infection after operative treatment for bone metastases [J]. J Surg Oncol, 2016, 114(8): 997-1003.
|
[27] |
Hussain AK, Vig KS, Cheung ZB, et al. The Impact of Metastatic Spinal Tumor Location on 30-Day Perioperative Mortality and Morbidity After Surgical Decompression[J]. Spine (Phila Pa 1976), 2018, 43(11): E648-E655.
|